The present invention provides pyrazole derivatives represented by the general formula: <；CHEM>； wherein R<；1>； represents H, an optionally substituted C1-6 alkyl group etc.； one of Q and T represents a group represented by the general formula: <；CHEM>； or a group represented by the general formula: <；CHEM>； while the other represents an optionally substituted C1-6 alkyl group etc.； R<；2>； represents H, a halogen atom, OH, an optionally substituted C1-6 alkyl group etc.； X represents a single bond, O or S； Y represents a single bond, a C1-6 alkylene group etc. ； Z represents CO or SO2； R<；4>； and R<；5>； represent H, an optionally substituted C1-6 alkyl group etc.； and R<；3>；, R<；6>； and R<；7>； represent H, a halogen atom etc., pharmaceutically acceptable salts thereof or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT1 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, and pharmaceutical compositions comprising the same, pharmaceutical uses thereof, and intermediates for production thereof.
